CSS LLC’s IGM Biosciences IGMS Stock Holding History

CSS LLC’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-23,500	Closed	-$628K	–	1160
2022 Q1	$628K	Buy	+23,500	New	+$438K	0.02%	558
2021 Q1	–	Sell	-6,700	Closed	-$591K	–	996
2020 Q4	$591K	Buy	+6,700	New	+$471K	0.02%	424

Other funds holding IGMS

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CSS LLC's IGMS Position: Q2 2022 in Review

CSS LLC sold out of IGM Biosciences (IGMS) in Q2 2022, closing a stake of 10,300 shares — an estimated $275K sold.

CSS LLC first reported a position in IGMS in Q1 2022 and held it in 1 quarter. The position peaked at $275K in Q1 2022. 89 funds tracked by Wall St. Rank hold IGMS as of Q2 2022.

CSS LLC reported no remaining IGM Biosciences position as of Q2 2022 after selling out during the quarter.
CSS LLC sold 10,300 IGM Biosciences shares in Q2 2022, an estimated $275K.
CSS LLC first reported a position in IGM Biosciences in Q1 2022 and held it in 1 quarter.
CSS LLC's IGM Biosciences position peaked at $275K in Q1 2022.
89 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2022.

Based on CSS LLC's 13F filing for Q2 2022, filed 15 Aug 2022.